MariMed seeks shareholder approval for 1-for-50 to 1-for-100 reverse stock split

MariMed filed a definitive proxy to seek stockholder authorization for a reverse stock split to support a potential U.S. exchange listing.

• The board would have discretion to execute a 1-for-50 to 1-for-100 share consolidation, or not proceed.
• A virtual special meeting is set for Oct. 28, 2026.
• The record date is Sept. 4, 2026.
• No fractional shares would be issued; holders would receive cash in lieu.